Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jennifer Mindell is active.

Publication


Featured researches published by Jennifer Mindell.


Hypertension | 2009

Continued Improvement in Hypertension Management in England. Results From the Health Survey for England 2006

Emanuela Falaschetti; Moushumi Chaudhury; Jennifer Mindell; Neil Poulter

This study evaluate whether blood pressure management has improved in England between 2003 and 2006, using cross-sectional, nationally representative, random samples of 8834 (in 2003) and 7478 (in 2006) noninstitutionalized adults (aged ≥16 years) of mean age 46 (in 2003) and 47 (in 2006) years. Overall mean blood pressure levels in 2006 were 130.8/74.2 mm Hg in men and 124.0/72.4 mm Hg in women. Awareness of hypertension increased significantly in the overall population (from 62% in 2003% to 66% in 2006; P<0.001), the increase being significant in women (from 64% in 2003% to 71% in 2006; P<0.001) but not in men (from 60% to 62%; P=0.26). Similarly, the proportion treated had risen significantly overall (from 48% to 54%; P<0.001) and in women (from 52% to 62%; P<0.001) but not in men (from 43% to 47%; P=0.05). Control rates (<140/90 mm Hg) were higher in 2006 than in 2003 (from 22% to 28%; P<0.001) and had increased more among women than men: from 23% to 32% in women (P<0.001) and from 21% to 24% in men (P=0.02). Among those on treatment, control rates increased from 46% to 52% (P<0.001; from 44% to 53% in women, P<0.001; and from 48% to 52% in men, P=0.18). The most common agents used for monotherapy have changed since 2003 and were angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Where ≥2 drugs were used, the most common antihypertensive class used varied by age and ethnicity. Awareness, treatment, and control of hypertension increased between 2003 and 2006, particularly in women, but opportunities for further improvement remain.


Journal of Epidemiology and Community Health | 2014

Fruit and vegetable consumption and all-cause, cancer and CVD mortality: analysis of Health Survey for England data.

Oyinlola Oyebode; Vanessa L.Z. Gordon-Dseagu; Alice Walker; Jennifer Mindell

Background Governments worldwide recommend daily consumption of fruit and vegetables. We examine whether this benefits health in the general population of England. Methods Cox regression was used to estimate HRs and 95% CI for an association between fruit and vegetable consumption and all-cause, cancer and cardiovascular mortality, adjusting for age, sex, social class, education, BMI, alcohol consumption and physical activity, in 65 226 participants aged 35+ years in the 2001–2008 Health Surveys for England, annual surveys of nationally representative random samples of the non-institutionalised population of England linked to mortality data (median follow-up: 7.7 years). Results Fruit and vegetable consumption was associated with decreased all-cause mortality (adjusted HR for 7+ portions 0.67 (95% CI 0.58 to 0.78), reference category <1 portion). This association was more pronounced when excluding deaths within a year of baseline (0.58 (0.46 to 0.71)). Fruit and vegetable consumption was associated with reduced cancer (0.75 (0.59–0.96)) and cardiovascular mortality (0.69 (0.53 to 0.88)). Vegetables may have a stronger association with mortality than fruit (HR for 2 to 3 portions 0.81 (0.73 to 0.89) and 0.90 (0.82 to 0.98), respectively). Consumption of vegetables (0.85 (0.81 to 0.89) per portion) or salad (0.87 (0.82 to 0.92) per portion) were most protective, while frozen/canned fruit consumption was apparently associated with increased mortality (1.17 (1.07 to 1.28) per portion). Conclusions A robust inverse association exists between fruit and vegetable consumption and mortality, with benefits seen in up to 7+ portions daily. Further investigations into the effects of different types of fruit and vegetables are warranted.


Journal of Epidemiology and Community Health | 2008

The epidemiology of fractures in England

Liam Donaldson; I. P. Reckless; Shaun Scholes; Jennifer Mindell; Nicola Shelton

Introduction: Fractures are a considerable public health burden in the United Kingdom but information on their epidemiology is limited. Objective: This study aims to estimate the true annual incidence and lifetime prevalence of fractures in England, within both the general population and specific groups, using a self-report methodology. Methods: A self-report survey of a nationally representative general population sample of 45 293 individuals in England, plus a special boost sample of 10 111 drawn from the ethnic minority population. Results: The calculated fracture incidence is 3.6 fractures per 100 people per year. Lifetime fracture prevalence exceeds 50% in middle-aged men, and 40% in women over the age of 75 years. Fractures occur with reduced frequency in the non-white population: this effect is seen across most black and minority ethnic groups. Conclusions: This study suggests that fractures in England may be more common than previously estimated, with an overall annual fracture incidence of 3.6%. Age-standardised lifetime fracture prevalence is estimated to be 38.2%. Fractures are more commonplace in the white population.


International Journal of Epidemiology | 2012

Cohort Profile: The Health Survey for England

Jennifer Mindell; Jane Biddulph; Vasant Hirani; Emanuel Stamatakis; Rachel Craig; Susan Nunn; Nicola Shelton

To monitor the health of the public in England, UK, the Central Health Monitoring Unit within the UK Department of Health commissioned an annual health examination survey, which became known as the Health Survey for England (HSE). The first survey was completed in 1991. The HSE covers all of England and is a nationally representative sample of those residing at private residential addresses. Each survey year consists of a new sample of private residential addresses and people. The HSE collects detailed information on mental and physical health, health-related behaviour, and objective physical and biological measures in relation to demographic and socio-economic characteristics of people aged 16 years and over at private residential addresses. There are two parts to the HSE; an interviewer visit, to conduct an interview and measure height and weight, then a nurse visit, to carry out further measurements and take biological samples. Since 1994, survey participants aged 16 years and over have been asked for consent to follow-up through linkage to mortality and cancer registration data, and from 2003, to the Hospital Episode Statistics database, thus converting annual cross-sectional survey data into a longitudinal study. Annual survey data (1994-2009) are available through the UK Data Archive.


Journal of Epidemiology and Community Health | 2002

A framework for the evidence base to support Health Impact Assessment

Michael Joffe; Jennifer Mindell

Objective: To introduce a conceptual structure that can be used to organise the evidence base for Health Impact Assessment (HIA). Background: HIA can be used to judge the potential health effects of a policy, programme or project on a population, and the distribution of those effects. Progress has been made in incorporating HIA into routine practice, especially (in the UK) at local level. However, these advances have mainly been restricted to process issues, including policy engagement and community involvement, while the evidence base has been relatively neglected. Relating policies to their impact on health: The key distinctive feature of HIA is that determinants of health are not taken as given, but rather as factors that themselves have determinants. Nine ways are distinguished in which evidence on health and its determinants can be related to policy, and examples are given from the literature. The most complete of these is an analysis of health effects in the context of a comparison of options. A simple model, the policy/risk assessment model (PRAM), is introduced as a framework that relates changes in levels of exposures or other risk factors to changes in health status. This approach allows a distinction to be made between the technical process of HIA and the political process of decision making, which involves lines of accountability. Extension of the PRAM model to complex policy areas and its adaptation to non-quantitative examples are discussed. Issues for the future: A sound evidence base is essential to the long term reputation of HIA. Research gaps are discussed, especially the need for evidence connecting policy options with changes in determinants of health. It is proposed that policy options could be considered as “exposure” variables in research. The methodology needs to be developed in the course of work on specific issues, concentrated in policy areas that are relatively tractable. Conclusions: A system of coordination needs to be established, at national or supranational level, building on existing initiatives. The framework suggested in this paper can be used to collate and evaluate what is already known, both to identify gaps where research is required and to enable an informed judgement to be made about the potential health impacts of policy options. These judgements should be made widely available for policy makers and for those undertaking health impact assessment.


The Lancet | 2014

Hypertension management in England: a serial cross-sectional study from 1994 to 2011

Emanuela Falaschetti; Jennifer Mindell; Craig S. Knott; Neil Poulter

BACKGROUND Hypertension is the leading risk factor contributing to the global burden of disease. We aimed to assess the change in blood pressure management between 1994 and 2011 in England with a series of annual surveys. METHODS We did a serial cross-sectional study of five Health Survey for England surveys based on nationally representative samples of non-institutionalised adults (aged ≥16 years). Mean blood pressure levels and rates of awareness, treatment, and control of hypertension were assessed. Hypertension was defined as systolic blood pressure 140 mm Hg or higher, diastolic blood pressure 90 mm Hg or higher, or receiving treatment for high blood pressure. FINDINGS The mean blood pressure levels of men and women in the general population and among patients with treated hypertension progressively improved between 1994 and 2011. In patients with treated hypertension, blood pressure improved from 150·0 (SE 0·59)/80·2 (0·27) mm Hg to 135·4 (0·58)/73·5 (0·41) mm Hg. Awareness, treatment, and control rates among men and women combined also improved significantly across each stage of this 17-year period, with the prevalence of control among treated patients almost doubling from 33% (SE 1·4) in 1994 to 63% (1·7) in 2011. Nevertheless, of all adults with survey-defined hypertension in 2011, hypertension was controlled in only 37%. INTERPRETATION If the same systematic improvement in all aspects of hypertension management continues until 2022, 80% of patients with treated hypertension will have controlled blood pressure levels with a potential annual saving of about 50,000 major cardiovascular events. FUNDING None.


American Journal of Public Health | 2006

Growing the field of health impact assessment in the United States: An agenda for research and practice

Andrew L. Dannenberg; Rajiv Bhatia; Brian L. Cole; Carlos Dora; Jonathan E. Fielding; Katherine Kraft; Diane McClymont-Peace; Jennifer Mindell; Chinwe Onyekere; James Roberts; Catherine L. Ross; Candace D. Rutt; Alex Scott-Samuel; Hugh H. Tilson

Health impact assessment (HIA) methods are used to evaluate the impact on health of policies and projects in community design, transportation planning, and other areas outside traditional public health concerns. At an October 2004 workshop, domestic and international experts explored issues associated with advancing the use of HIA methods by local health departments, planning commissions, and other decisionmakers in the United States. Workshop participants recommended conducting pilot tests of existing HIA tools, developing a database of health impacts of common projects and policies, developing resources for HIA use, building workforce capacity to conduct HIAs, and evaluating HIAs. HIA methods can influence decisionmakers to adjust policies and projects to maximize benefits and minimize harm to the publics health.


Journal of Epidemiology and Community Health | 2004

Enhancing the evidence base for health impact assessment

Jennifer Mindell; Annette Boaz; Michael Joffe; Sarah Curtis; M Birley

Health impact assessment differs from other purposes for which evidence is collated in a number of ways, including: the focus on complex interventions or policy and their diverse effects on determinants of health; the need for evidence on the reversibility of adverse factors damaging to health; the diversity of the evidence in terms of relevant disciplines, study designs, quality criteria and sources of information; the broad range of stakeholders involved; the short timescale and limited resources generally available; the pragmatic need to inform decision makers regardless of the quality of the evidence. These have implications for commissioning and conducting reviews. Methods must be developed to: facilitate comprehensive searching across a broad range of disciplines and information sources; collate appropriate quality criteria to assess a range of study designs; synthesise different kinds of evidence; and facilitate timely stakeholder involvement. Good practice standards for reviews are needed to reduce the risk of poor quality recommendations. Advice to decision makers must make explicit limitations resulting from absent, conflicting, or poor quality evidence.


Journal of Epidemiology and Community Health | 2003

A glossary for health impact assessment

Jennifer Mindell; E Ison; Michael Joffe

Health impact assessments look at the effect on health of policies implemented outside the healthcare sector. A glossary is provided in the following article.


Tobacco Control | 2012

Impact of smoke-free legislation on children's exposure to secondhand smoke: cotinine data from the Health Survey for England

Martin J. Jarvis; Michelle Sims; Anna Gilmore; Jennifer Mindell

Objective To examine the impact of the ban on smoking in enclosed public places implemented in England in July 2007 on childrens exposure to secondhand tobacco smoke. Design Repeated cross-sectional surveys of the general population in England. Setting The Health Survey for England. Participants Confirmed non-smoking children aged 4–15 with measured saliva cotinine participating in surveys from 1998 to 2008, a total of 10 825 children across years. Main outcome measures The proportion of children living in homes reported to be smoke-free; the proportion of children with undetectable concentrations of cotinine; geometric mean cotinine as an objective indicator of overall exposure. Results Significantly more children with smoking parents lived in smoke-free homes in 2008 (48.1%, 95% CI 43.0% to 53.1%) than in either 2006 (35.5%, 95% CI 29.7% to 41.7%) or the first 6 months of 2007, immediately before the ban came into effect (30.5%, 95% CI 19.7% to 43.9%). A total of 41.1% (95% CI 38.9% to 43.4%) of children had undetectable cotinine in 2008, up from 34.0% (95% CI 30.8% to 37.3%) in 2006. Geometric mean cotinine in all children combined was 0.21 ng/ml (95% CI 0.20 to 0.23) in 2008, slightly lower than in 2006, 0.24 ng/ml (95% CI 0.21 to 0.26). Conclusions Predictions that the 2007 legislative ban on smoking in enclosed public places would adversely affect childrens exposure to tobacco smoke were not confirmed. While overall exposure in children has not been greatly affected by the ban, the trend towards the adoption of smoke-free homes by parents who themselves smoke has received fresh impetus.

Collaboration


Dive into the Jennifer Mindell's collaboration.

Top Co-Authors

Avatar

Shaun Scholes

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J Stockton

University College London

View shared research outputs
Top Co-Authors

Avatar

Nicola Shelton

University College London

View shared research outputs
Top Co-Authors

Avatar

Pr Anciaes

University College London

View shared research outputs
Top Co-Authors

Avatar

Hanna Tolonen

National Institute for Health and Welfare

View shared research outputs
Top Co-Authors

Avatar

Kari Kuulasmaa

National Institute for Health and Welfare

View shared research outputs
Top Co-Authors

Avatar

Päivikki Koponen

National Institute for Health and Welfare

View shared research outputs
Top Co-Authors

Avatar

Ashley Dhanani

University College London

View shared research outputs
Top Co-Authors

Avatar

Marilyn A. Roth

University College London

View shared research outputs
Researchain Logo
Decentralizing Knowledge